The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Ryzhova M.V.

Burdenko Neurosurgical Center

Galstyan S.A.

Burdenko Neurosurgical Center

Telysheva E.N.

Burdenko Neurosurgical Center

Pitskhelauri D.I.

Burdenko Neurosurgical Center

Kosyrkova A.V.

Burdenko Neurosurgical Center

Latyshev Ya.A.

Burdenko Neurosurgical Center

IDH-mutant brainstem glioma

Authors:

Ryzhova M.V., Galstyan S.A., Telysheva E.N., Pitskhelauri D.I., Kosyrkova A.V., Latyshev Ya.A.

More about the authors

Journal: Burdenko's Journal of Neurosurgery. 2022;86(6): 52‑57

Read: 2777 times


To cite this article:

Ryzhova MV, Galstyan SA, Telysheva EN, Pitskhelauri DI, Kosyrkova AV, Latyshev YaA. IDH-mutant brainstem glioma. Burdenko's Journal of Neurosurgery. 2022;86(6):52‑57. (In Russ., In Engl.)
https://doi.org/10.17116/neiro20228606152

Recommended articles:
Glymphatic system in health and disease: a narrative review. Burdenko's Journal of Neurosurgery. 2025;(4):112-118
Surgery for gliomas of Broca’s area. Burdenko's Journal of Neurosurgery. 2025;(6):38-45
Topic mode­ling of lite­rature in glioma radiomics. Burdenko's Journal of Neurosurgery. 2025;(6-2):57-66
Machine learning models for brain tumors differential diagnosis. Russian Journal of Preventive Medi­cine. 2025;(9):87-93

References:

  1. WHO Classification of Tumours Online. International Agency for Research on Cancer. https://tumourclassification.iarc.who.int/chapters/45
  2. Sano K, Matsuda K-I, Kawanami K, Kanemura Y, Ohe R, Sonoda Y. Malignant progression of an IDH mutant brainstem glioma in adult. NMC Case Report Journal. 2021;8(1):301-307.  https://doi.org/10.2176/nmccrj.cr.2020-0151
  3. Zhou C, Zhao H, Yanga F, Huangfu L, Dong C, Wang S, Zhang J. Clinical and genetic features of brainstem glioma in adults: a report of 50 cases in a single center. Journal of Clinical Neurology. 2021;17(2):220-228.  https://doi.org/10.3988/jcn.2021.17.2.220
  4. Eschbacher KL, Ida CM, Johnson DR, Alvi MA, Jenkins SM, Ruff MW, Kerezoudis P, Neth BJ, Pasion RM, Daniels DJ, Kizilbash SH, Raghunathan A. Diffuse gliomas of the brainstem and cerebellum in adults show molecular heterogeneity. The American Journal of Surgical Pathology. 2021;45:1082-1090. https://doi.org/10.1097/PAS.0000000000001690
  5. Banan R, Stichel D, Bleck A, Hong B, Lehmann U, Suwala A, Reinhardt A, Schrimpf D, Buslei R, Stadelmann C, Ehlert K, Prinz M, Acker T, Schittenhelm J, Kaul D, Schweizer L, Capper D, Harter PN, Etminan N, Jones DTW, Pfister SM, Herold-Mende C, Wick W, Sahm F, von Deimling A, Hartmann C, Reuss DE. Infratentorial IDH-mutant astrocytoma is a distinct subtype. Acta Neuropathologica. 2020;140(4):569-581.  https://doi.org/10.1007/s00401-020-02194-y
  6. Bangalore Yogananda CG, Shah BR, Vejdani-Jahromi M, Nalawade SS, Murugesan GK, Yu FF, Pinho MC, Wagner BC, Mickey B, Patel TR, Fei B, Madhuranthakam AJ, Maldjian JA. A novel fully automated MRI-based deep-learning method for classification of IDH mutation status in brain gliomas. Neuro-Oncology. 2020;22(3):402-411.  https://doi.org/10.1093/neuonc/noz199
  7. Lu J, Li X, Li H. Perfusion parameters derived from MRI for preoperative prediction of IDH mutation and MGMT promoter methylation status in glioblastomas. Magnetic Resonance Imaging. 2021;83:189-195.  https://doi.org/10.1016/j.mri.2021.09.005
  8. Decuyper M, Bonte S, Deblaere K, Van Holen R. Automated MRI based pipeline for segmentation and prediction of grade, IDH mutation and 1p19q co-deletion in glioma. Computerized Medical Imaging and Graphics. 2021;88:101831. https://doi.org/10.1016/j.compmedimag.2020.101831
  9. Kim M, Jung SY, Park JE, Jo Y, Park SY, Nam SJ, Kim JH, Kim HS. Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma. European Radiology. 2020;30(4):2142-2151. https://doi.org/10.1007/s00330-019-06548-3
  10. Choi YS, Bae S, Chang JH, Kang SG, Kim SH, Kim J, Rim TH, Choi SH, Jain R, Lee SK. Fully automated hybrid approach to predict the IDH mutation status of gliomas via deep learning and radiomics. Neuro-Oncology. 2021;23(2):304-313.  https://doi.org/10.1093/neuonc/noaa177
  11. Manikis GC, Ioannidis GS, Siakallis L, Nikiforaki K, Iv M, Vozlic D, Surlan-Popovic K, Wintermark M, Bisdas S, Marias K. Multicenter DSC-MRI-Based Radiomics Predict IDH Mutation in Gliomas. Cancers. 2021;13(16):3965. https://doi.org/10.3390/cancers1316396
  12. Cindil E, Sendur HN, Cerit MN, Erdogan N, Celebi F, Dag N, Celtikci E, Inan A, Oner Y, Tali T. Prediction of IDH Mutation Status in High-grade Gliomas Using DWI and High T1-weight DSC-MRI. Academic Radiology. 2022;29(suppl 3):52-62.  https://doi.org/10.1016/j.acra.2021.02.002
  13. Kugel H. Editorial for «Predicting Isocitrate Dehydrogenase (IDH) Mutation Status in Gliomas Using Multiparameter MRI Radiomics Features». Magnetic Resonance Imaging. 2021;53(5):1408-1409. https://doi.org/10.1002/jmri.27472
  14. Behling F, Steinhilber J, Tatagiba M, Bisdas S, Schittenhelm J. IDH1 R132H mutation in a pilocytic astrocytoma: a case report. International Journal of Clinical and Experimental Pathology. 2015;8(9):11809-11813.
  15. Ellezam B, Theeler BJ, Walbert T, Mammoser AG, Horbinski C, Kleinschmidt-DeMasters BK, Perry A, Puduvalli V, Fuller GN, Bruner JM, Aldape KD. Low rate of R132H IDH1 mutation in infratentorial and spinal cord grade II and III diffuse gliomas. Acta Neuropathology. 2012;124(3):449-451.  https://doi.org/10.1007/s00401-012-1011-7
  16. Ida CM, Lambert SR, Rodriguez FJ, Voss JS, Mc Cann BE, Seys AR, Halling KC, Collins VP, Giannini C. BRAF alterations are frequent in cerebellar low-grade astrocytomas with diffuse growth pattern. Journal of Neuropathology and Experimental Neurology. 2012;71(7):631-639.  https://doi.org/10.1097/NEN.0b013e31825c448a
  17. Javadi SA, Hartmann C, Walter GF, Banan R, Samii A. IDH1 Mutation in brain stem glioma: case report and review of literature. Asian Journal of Neurosurgery. 2018;13(2):414-417.  https://doi.org/10.4103/1793-5482.228540
  18. Picca A, Berzero G, Bielle F, Touat M, Savatovsky J, Polivka M, Trisolini E, Meunier S, Schmitt Y, Idbaih A, Hoang-Xuan K, Delattre J-Y, Mokhtari K, Di Stefano AL, Sanson M. FGFR1 actionable mutations, molecular specificities, and outcome of adult midline gliomas. Neurology. 2018;90(23):2086-2094. https://doi.org/10.1212/WNL.0000000000005658
  19. Reyes-Botero G, Giry M, Mokhtari K, Labussiere M, Idbaih A, Delattre JY, Laigle-Donadey F, Sanson M. Molecular analysis of diffuse intrinsic brainstem gliomas in adults. Journal of Neuro-Oncology. 2014;116(2):405-411.  https://doi.org/10.1007/s11060-013-1312-2
  20. Chang EK, Smith-Cohn MA, Tamrazi B, Ji J, Krieger M, Holdhoff M, Eberhart CG, Margol AS, Cotter JA. IDH-mutant brainstem gliomas in adolescent and young adult patients: Report of three cases and review of the literature. Brain pathology. 2021;31(4):e12959. https://doi.org/10.1111/bpa.12959
  21. Zhou J, Lai M, Ni Y, Li S, Zhen J, Du F, Zhang X, Song C, Cai L. Case Report: Clinicopathological and Genetic Features of IDH-Mutant Brainstem Glioma in Adults: Report of Five Cases. Pathology oncology research. 2022;28:1610408. https://doi.org/10.3389/pore.2022.1610408
  22. Matsumura N, Ikota H, Yamazaki T, Nakata S, Nobusawa S, Hirato J, Yoshimoto Y, Yokoo H. Cerebellar high-grade astrocytoma with IDH mutations in the elderly: A report of two cases. Neuropathology: official journal of the Japanese Society of Neuropathology. 2018. https://doi.org/10.1111/neup.12468

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.